Device recall · July 6, 2016
Sodium Chloride Inhalation Solution recall
Why: Lack of Assurance of Sterility: Internal dye ingress test failure to assure the integrity of the vial.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sodium Chloride Inhalation Solution, USP 7%, 60 x 4 mL Sterile Unit-Dose Vials, Rx Only, NDC 0487-9007-60. A vial contains sterile, preservation-free, clear, colorless, aqueous solution as labeled for induction of sputum production where specimen collection is indicated. For respiratory therapy, Solium Chloride Inhalation Solution USP, 3% is used in conjunction with a nebulizer
- Lots / codes
Lot Number N4753A, Exp 11/16
- Quantity
- 13,692 cartons
- Company
- Nephron Pharmaceuticals Corp., Orlando, FL
- Distribution
- Worldwide Distribution - US including AL, AR, AZ, CA, CO, CT, FL, GA, IL, KY, LA, MA, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NY, OH, OK, OR, PA, PR, SC, TN, TX, UT, VA, VT, WA, WI, WV and Internationally to Canada.
- Initiated
- November 16, 2015 · Voluntary: Firm initiated
- Classified
- June 27, 2016
- Reported
- July 6, 2016
- Ended
- January 9, 2017
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.